HK1161119B - Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement - Google Patents
Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement Download PDFInfo
- Publication number
- HK1161119B HK1161119B HK12101920.9A HK12101920A HK1161119B HK 1161119 B HK1161119 B HK 1161119B HK 12101920 A HK12101920 A HK 12101920A HK 1161119 B HK1161119 B HK 1161119B
- Authority
- HK
- Hong Kong
- Prior art keywords
- eculizumab
- patients
- treatment
- complement
- life
- Prior art date
Links
Claims (1)
- Pharmazeutische Zusammensetzung zur Verwendung in der Behandlung eines Patienten, der an paroxysmaler nächtlicher Hämoglobinurie (PNH) leidet, wobei die Zusammensetzung eine 300-mg-Eculizumab-Einmal-Darreichungsform ist, umfassend 30 ml einer 10 mg Eculizumab pro ml enthaltenden sterilen, konservierungsmittelfreien Lösung.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US78307006P | 2006-03-15 | 2006-03-15 | |
| US783070P | 2006-03-15 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HK1161119A1 HK1161119A1 (en) | 2012-08-24 |
| HK1161119B true HK1161119B (en) | 2018-01-05 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2359834B1 (de) | Hemmer des Komplements zur Behandlung der paroxysmalen nächtlichen Haemoglobinurie | |
| HK1161119B (en) | Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement | |
| HK40105220A (en) | Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement | |
| HK1235319A1 (en) | Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement | |
| HK1235319B (en) | Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement | |
| HK1232786A1 (en) | Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement | |
| AU2013206214A1 (en) | Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement |